Urol. praxi. 2024;25(3):114-120 | DOI: 10.36290/uro.2024.054

Current treatment options for lower urinary tract infections

MUDr. Aleš Čermák, Ph.D.
Chirurgické oddělení, Vojenská nemocnice Brno

Urinary tract infections (UTIs) and upper respiratory tract infections are two of the most common infectious diseases in the population. UTIs are among the most common issues addressed by the general practitioner, urologist and gynaecologist in collaboration with a microbiologist. Cystitis is the most frequent type. Treatment of the infection itself is usually not challenging and warrants the use of antimicrobial drugs. Of major importance is the knowledge of suspected causative agents and commencement of appropriate treatment. When deciding on the method of treatment, a rational evaluation of all the results is required. The basic consideration should also include aspects of the issue of overuse of - often non-indicated - antibiotic treatment.

Keywords: urinary tract infections, uncomplicated urinary tract infections, complicated urinary tract infections, antimicrobial treatment.

Accepted: October 1, 2024; Published: November 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čermák A. Current treatment options for lower urinary tract infections. Urol. praxi. 2024;25(3):114-120. doi: 10.36290/uro.2024.054.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 14.11.2025

    References

    1. Horáčková M. Akutnî a akutně recidivujîcî infekce močových cest. Med. praxi. 2010;7(3):135-138.
    2. Bébrová E. Mikrobiologické aspekty patogeneze infekcî močových cest. In: Teplan V, Horáčková M, Bébrová E, Janda J, et al. Infekce ledvin a močových cest. Praha: Grada Publishing 2004:31-44.
    3. Slîva J, Fait T, a kol. Samoléčba v gynekologii aneb sama sobě gynekologem. Vol 2012.
    4. Čechová M. Možnosti v léčbě močových infekcî v ordinaci praktického lékaře. Med. praxi 2019;16(2):79-84 Go to original source...
    5. Abdullatif A, Kamran A, Iftikhar Z, et al. Int Urogynecol J. 2015;26(6):795-804. Go to original source...
    6. Bukovský I. Nová miniencyklopedie přîrodnî léčby. 1. vyd. Praha: BOOKMEDIA, s. r. o, 2015:224 s. ISBN: 978-80-880-3628-9.
    7. Zámečnîk L, Macek P. Modernî farmakoterapie v urologii. 1. Vyd. Praha: Maxdorf, 2012:172 s. ISBN: 978-80-734-5276-6.
    8. Behinová M, Kaisetová K. Nová velká kniha o mateřstvî + CD. 3. vyd. Praha: Mladá fronta, 2012:368 s. ISBN: 978-80-204-2816-5.
    9. Ševčîková A, Ševčîk P. Principy antimikrobiálnî léčby u uroinfekcî. Urol List. 2005;3(2).
    10. Bébrová E. Bakteriologická diagnostika infekce močových cest, racionálnî léčba antibiotiky a chemoterapeutiky. In: Teplan V, Horáčková M, Bébrová E, Janda J, et al. Infekce ledvin a močových cest. Praha: Grada 2004:45-62.
    11. Wagenlehner FM, Naber KG. Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles. Expert Rev Anti Infect Ther. 2004;2:923-931. Go to original source... Go to PubMed...
    12. Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis 2019;68:e83-e110. Go to original source... Go to PubMed...
    13. Horáčková M. Močové infekce u seniorů a léčba asymptomatické infekce močovéhoé traktu. Postgraduální nefrologie. 2022;20(4):11-14.
    14. Nicolle LE, Bradley S, Colgan R, et al. Infectious diseases so- ciety of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clinical Infectious Diseases. 2005;40:643-654. Go to original source... Go to PubMed...
    15. Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015;15(11):1324-1333. Go to original source... Go to PubMed...
    16. Bonkat G, Pickard R, Bartoletti R, et al. EAU Guidelines on Urological Infections. EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen 2018. Publisher: EAU Guidelines Office. Place published: Arnhem, The Netherlands. Dostupné z: https://uroweb.org/guideline/urological-infections/.
    17. Rodriguez-Pardo D, et al. Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial. Eur J Clin Microbiol Infect Dis. 2021;40:2411. https://pubmed.ncbi.nlm.nih.gov/33864153. Go to original source... Go to PubMed...
    18. Jami SA, et al. The necessity of treating asymptomatic bacteriuria with antibiotics in the perioperative period of joint arthroplasty: a metaanalysis. Turk J Med Sci, 2021;51:464. https://pubmed.ncbi.nlm.nih.gov/33021755. Go to original source... Go to PubMed...
    19. Wang C, et al. Current evidence does not support systematic antibiotherapy prior to joint arthroplasty in patients with asymptomatic bacteriuria meta analysis. Int Orthop, 2018;42:479. Go to original source... Go to PubMed...
    20. Fajfr M, Louda M, Paterová P, et al. Fosfomycin trometamol - staronové antibiotikum v urologické praxi. Urol. praxi. 2015;16(4):148-155.
    21. Kladenský J. Nekomplikované infekce dolnîch močových cest u žen - možnosti léčby a prevence Urol. praxi. 2018;19(1):10-15. Go to original source...
    22. Kladenský J, Toršová V, Chmelařová E. Přînos nifuratelu pro léčbu akutnîch nekomplikovaných uroinfekcî. Urol. praxi. 2006;7:109-110.
    23. Gupta K, et al. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents, 2002;19:554. https://pubmed.ncbi.nlm.nih.gov/12135847. Go to original source... Go to PubMed...
    24. Warren JW, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis, 1999;29:745. https://pubmed.ncbi.nlm.nih.gov/10589881. Go to original source... Go to PubMed...
    25. Vazquez, JC, et al. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev, 2000: CD002256. https://pubmed.ncbi.nlm.nih.gov/10908537.
    26. Kolář M. Klinicko-mikrobiologické podklady racionálnî antibiotické léčby. Praha: Trios 2002.
    27. Hummers-Pradier E, Ohse AM, Koch M, et al. Urinary tract infection in men. Int J Clin Pharmacol Ther. 2004;42:360-366. Go to original source... Go to PubMed...
    28. Bonkat GR, Bartoletti F, Bruyère T, et al. EAU Guidelines on Urological Infections. EAU Guidelines. Publisher: EAU Guidelines Office. Place published: Arnhe.
    29. Wagenlehner FM, et al. Antimicrobials in urogenital infections. Int J Antimicrob Agents, 2011;38:Suppl: 3. https://pubmed.ncbi.nlm.nih.gov/22019184. Go to original source... Go to PubMed...
    30. Vickovic N, et al. Metronidazole 1.5 gram dose for 7 or 14 days in the treatment of patients with chronic prostatitis caused by Trichomonas vaginalis: A randomized study. J Chemother. 2010;22:364. https://pubmed.ncbi.nlm.nih.gov/21123162. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.